CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Marksans Pharma Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Marksans Pharma Ltd
11TH FLOOR,
GRANDEUR, VEERA DESAI EXTENSION ROAD, OS
Phone: +91 2240012000p:+91 2240012000 MUMBAI, 400053  India Ticker: MARKSANSMARKSANS
Business Summary
Marksans Pharma Limited is engaged in research, manufacture, marketing and sales of pharmaceutical formulations. It operates two manufacturing facilities in Goa and maintains two research and development centers; one located in Goa and the other in Navi Mumbai. Its focus areas lie in the over the counter (OTC) & prescription drugs that have ranging applications across fields like pain management, cough and cold, digestives, cardiovascular system (CVS), central nervous system (CNS) oncology, antidiabetic, and antibiotics. It has a diverse product portfolio of tablets (plain, enteric coated and film-coated), hard capsules, soft gelatin capsules, oral liquids and ointments. OTC product development for therapeutic categories such as pain management, upper respiratory, digestive health, vitamins, supplements, and anti-allergic treatments. Its prescription - Rx therapeutic segments include CVS, CNS, oncology, anti-diabetics and anti-biotic. It markets and distributes OTC products in Germany.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20263/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Managing Director Mark B.Saldanha 52 10/6/2015 10/6/2015
Group Chief Financial Officer JitendraSharma 55
Company Secretary, Compliance Officer HarshavardhanPanigrahi 1/1/2024 2/16/2009
10 additional Officers and Directors records available in full report.

Business Names
Business Name
524404
MARKSANS
Marksans Pharma Limited
Marksans Pharma Limited (Parent)

General Information
Number of Employees: 1,349 (As of 3/31/2025)
Outstanding Shares: 453,163,746 (As of 3/31/2026)
Shareholders: 262,565
Stock Exchange: NSE
Fax Number: +91 2240012099


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, July 26, 2026